|
Jul 18
|
MHRA approves needle-free adrenaline nasal spray for anaphylaxis
|
|
Jul 18
|
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
|
|
Jul 15
|
ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy?
|
|
Jul 15
|
Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?
|
|
Jul 15
|
What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing'
|
|
Jul 14
|
Spotlight On Viemed Healthcare And 2 More Growth Stocks With Strong Insider Ownership
|
|
Jul 14
|
Insider-Owned Growth Stocks To Watch In July 2025
|
|
Jul 11
|
Top Growth Companies With Insider Ownership July 2025
|
|
Jul 11
|
Top Growth Companies With Strong Insider Ownership July 2025
|
|
Jul 1
|
Top Growth Companies With Insider Ownership In July 2025
|
|
Jun 27
|
Top Growth Companies With Significant Insider Ownership
|
|
Jun 24
|
Top Growth Stocks With Significant Insider Ownership In June 2025
|
|
Jun 24
|
3 Growth Companies With High Insider Ownership And 17% Revenue Growth
|
|
Jun 23
|
High Growth Tech Stocks in US for June 2025
|
|
Jun 15
|
Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”
|
|
Jun 12
|
Top Growth Stocks With Strong Insider Ownership In June 2025
|
|
May 27
|
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
|
|
Mar 21
|
ARS Pharmaceuticals Inc (SPRY) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...
|
|
Mar 21
|
Q4 2024 ARS Pharmaceuticals Inc Earnings Call
|
|
Mar 20
|
ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here's Why.
|